trending Market Intelligence /marketintelligence/en/news-insights/trending/knqajieuh2ta4tnec6mwqg2 content
Log in to other products

Login to Market Intelligence Platform


Looking for more?

Contact Us

Request a Demo

You're one step closer to unlocking our suite of comprehensive and robust tools.

Fill out the form so we can connect you to the right person.

  • First Name*
  • Last Name*
  • Business Email *
  • Phone *
  • Company Name *
  • City *

* Required

In this list

Nasdaq grants Medical Transcription another 180 days to regain compliance

Street Talk Episode 51 - Goldman Talks Libor Transition, Recent SOFR Volatility

#ChangePays: Although Still Underrepresented, Women in the C-Suite are Driving Profitability

Cable Nets For Kids Enjoy Wide Carriage On Skinny Bundles


Power Forecast Briefing: Fleet Transformation, Under-Powered Markets, and Green Energy in 2018

Nasdaq grants Medical Transcription another 180 days to regain compliance

The Nasdaq Stock Market granted Medical Transcription Billing Corp. another 180 calendar days, or until June 19, 2017, to regain compliance with its minimum $1.00 bid price per share listing requirement.

The company was unable to regain compliance by Dec. 21, 2016, the previous deadline. Nasdaq said the company is eligible for a second compliance period, as it plans to remove the deficiency during the second compliance period by effecting a reverse stock split, if necessary, and meets the continued listing requirement for market value of publicly held shares and all other applicable requirements for initial listing.

The closing bid price of Medical Transcription's security must be at least $1.00 per share for a minimum of 10 consecutive business days to regain compliance. The company said it will monitor the closing bid price of its common stock and may consider implementing available options to regain compliance.